Skip to main content
SpringerLink
Log in

Monoclonal antibodies in bladder cancer cytology

  • Published:
World Journal of Urology Aims and scope Submit manuscript

Summary

Conventional urinary cytology is the only routine noninvasive test accepted for the early detection and follow-up of bladder cancer. However, accuracy is achieved only in high-grade tumors and the method requires an experienced cytopathologist. Hybridoma technology has been developed to identify molecules or antigenic epitopes associated with malignant transformation. This report discusses the various monoclonal antibodies that have been generated against transitional-cell carcinoma (TCC) of the bladder and can be used to detect exfoliated cancer cells in urine. Several antibodies that recognize epitopes related to Lewis X carbohydrate molecules react with TCC cells of various grades, with the detection rate ranging from 70%–90%. Further studies are required to standardize the methodology and to determine the value of immunocytology in the management of bladder cancer patients. However, this approach shows great promise for improving diagnostic accuracy and for pedicting biological aggresiveness and response to therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arndt R, Dürkopf H, Huland H, Donn F, Loening TH, Kalthoff H (1987) Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells. J Urol 137:758

    Google Scholar 

  2. Chopin DK, deKernion JB, Rosenthal DL, Fahey JL (1985) Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing. J Urol 134:260

    Google Scholar 

  3. Espositi PL, Moberger G, Zajicek J (1970) The cytologic diagnosis of transitional cell tumor of the urinary bladder and its histological bases. Acta Cytol 14:145

    Google Scholar 

  4. Feizi T (1985) Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are oncodevelopmental antigens. Nature 314:53

    Google Scholar 

  5. Fradet Y (1990) Biological markers of prognosis in invasive bladder cancer. Semin Oncol 17:533

    Google Scholar 

  6. Fradet Y, Cordon-Cardo C, Thomson T, Daly ME, Whitmore WF, Lloyd KO, Melamed MR, Old LJ (1984) Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. PNAS 81:224

    Google Scholar 

  7. Fradet Y, Cordon-Cardo C, Whitmore WF, Melamed MR, Old LJ (1986) Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth charecteristics. Cancer Res 46:5183

    Google Scholar 

  8. Fradet Y, Islam N, Boucher L, Parent-Vaugeois C, Tradif M (1987) Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies. PNAS 84:7227

    Google Scholar 

  9. Fradet Y, Tardif M, Bourget L, Robert J, Laval University Group (1990) Clinical cancer progression in urinary bladder tumors: evaluation by multiparameter flow cytometry with monoclonal antibodies. Cancer Res 50:432

    Google Scholar 

  10. Hijazi A, Devonec M, Bouvier R, Escourrou G, Longin A, Perrin P, Revillard JP (1989) Phenotyping of 76 human bladder tumors with a panel of monoclonal antibodies: correlation between pathology, surface immunofluorescence and DNA content. Eur J Cancer Clin Oncol 25:777

    Google Scholar 

  11. Huland H, Arndt R, Huland E, Loening TH, Steffens M (1987) Monoclonal antibody 486 P 3/12: a valuable bladder carcinoma marker for immunocytology. J Urol 137:654

    Google Scholar 

  12. Huland H, Huland E, Schneider AW (1990) Quantitative immunocytology in the management of patients with superficial bladder carcinoma: I. A marker to identify patients who do not require prophylaxis. J Urol 144:637

    Google Scholar 

  13. Lloyd KO, Old LJ (1989) Human monoclonal antibodies to glycolipids and carbohydrate antigens: dissection of the humoral immune response in cancer patients. Cancer Res 49:3445

    Google Scholar 

  14. Longin A, Hijazi A, Berger-Dutrieux N, Escourrou G, Bouvier R, Richer G, Mironneau I, Fontanière B, Devonec M, Laurent JC (1989) A monoclonal antibody (BL2–10D1) reacting with a bladder-cancer-associated antigen. Int J Cancer 43:183

    Google Scholar 

  15. Longin A, Fontanière B, Berger-Dutrieux N, Devonec M, Laurent JC (1990) A useful monoclonal antibody (BL2–10D1) to identify tumor cells in urine cytology. Cancer 65:1412

    Google Scholar 

  16. Murphy WM, Soloway MS, Jukkola AF, Crabtree W, Ford K (1984) Urinary cytology and bladder cancer: the features of transitional cell neoplasms. Cancer 53:1555

    Google Scholar 

  17. Ooms ECM, Anderson WAD, Alons CL, Boon ME, Veldhuizen RW (1983) Analysis of the performance of pathologists in the grading of bladder tumors. Hum Pathol 2:140

    Google Scholar 

  18. Papanicolaou GN, Marshall VF (1945) Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 101:519

    Google Scholar 

  19. Rettig WJ, Cordon-Cardo C, Oettgen Ng JS, Old L, Lloyd KO (1985) High-molecular-weight glycoproteins of human teratocarcinoma defined by monocloncal antibodies to carbohydrate determinants. Cancer Res 45:815

    Google Scholar 

  20. Rife CC, Farrow GM, Utz DC (1979) Urine cytology of transitional cell neoplasms. Urol Clin North Am 6:599

    Google Scholar 

  21. Sheinfeld J, Reuter VE, Melamed MR, Fair WR, Morse M, Sogani PC, Herr WH, Whitmore WF, Cordon-Cardo C (1990) Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. J Urol 143:285

    Google Scholar 

  22. Singhal AK, Orntoft TF, Nudelman E, Nance S, Schibig L, Stroud MR, Clausen H, Hakomori S (1990) Profiles of Lewis containing glycoproteins and glycolipids in sera of patients with adenocarcinoma. Cancer Res 50:1375

    Google Scholar 

  23. Umiker W, Lapides J, Sovrenne R (1962) Exfoliative cytology of papillomas and intra-epithelial carcinomas of the urinary bladder. Acta Cytol 6:255

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d'Urologie, Hôpital Henri Mondor, F-94000, Creteil, France

    D. K. Chopin & J.-C. Laurent

  2. Centre Régional de Transfusion Sanguine, F-13005, Marseille, France

    D. K. Chopin & J.-C. Laurent

Authors
  1. D. K. Chopin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J.-C. Laurent
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chopin, D.K., Laurent, JC. Monoclonal antibodies in bladder cancer cytology. World J Urol 9, 75–78 (1991). https://doi.org/10.1007/BF00184037

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00184037

Keywords

Search

Navigation